viral replication inhibitor (AIkido Pharma)

N/A

Report date: 2025/01/26 16:41:25
NME

Base Information

Drug Nameviral replication inhibitor (AIkido Pharma)
Drug Alias Nameviral replication inhibitor (University of Maryland Baltimore Count)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus InfectionsMarburg Virus Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesDominari Holdings Inc
Inactive Companies +[1]  N/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus InfectionsMarburg Virus Disease +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A